Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients

Clinical and Experimental Immunology

Volumn 110, Issue 2, 1997, Pages 174-181

  Thon, V ^a,b   Wolf, H M ^a   Sasgary, M ^a   Litzman, J ^b   Samstag, A ^a   Hauber, I ^a   Lokaj, J ^b   Eibl, M M ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MASARYK UNIVERSITY   (Czech Republic)

Author keywords

Activation; CD40 ligand; Common variable immunodeficieney; Costimulation; T cell receptor

Indexed keywords

CD4 ANTIGEN; CD40 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ACCESSORY CELL; ANTIBODY PRODUCTION; ARTICLE; CELL PROLIFERATION; COMMON VARIABLE IMMUNODEFICIENCY; CROSS LINKING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPOGAMMAGLOBULINEMIA; LIGAND BINDING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0030831463     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.tb08314.x     Document Type: Article

References (48)

1. Rosen FS, Wedgwood JP, Eibl M et al. Primary Immunodeficiency Diseases.Report of a WHO Scientific Group. Clin Exp Immunol 1995; 99(Suppl. 1):1-24.
2. Saxon A, Sidell N, Zhang K. B cells from subjects with CVI can be driven to Ig production in response to CD40 stimulation. Cell Immunol 1992; 144:169-81.
3. Nonoyama S, Farrington M, Ishida H, Howard M, Ochs HD. Activated B cells from patients with common variable immunodeficiency proliferate and synthesize immunoglobulin. J Clin Invest 1993; 92:1282-7.
4. Eisenstein EM, Chua K, Strober W. B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10. J Immunol 1994; 152:5957-68.
5. Sneller MC, Strober W. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol 1990; 144:3762-9.
6. + T cell differentiation. J Clin Immunol 1993; 13:247-58.
7. North ME, Webster AD, Farrant J. Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C. Clin Exp Immunol 1991; 85:198-201.
8. Fischer MB, Hauber I, Vogel E, Wolf HM, Mannhalter JW, Eibl MM. Defective interleukin-2 and interferon-gamma gene expression in response to antigen in a subgroup of patients with common variable immunodeficiency. J Allergy Clin Immunol 1993; 92:340-52.
9. Stagg AJ, Funauchi M, Knight SC, Webster AD, Farrant J. Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1994; 96:48-53.
10. Fischer MB, Hauber I, Eggenbauer H et al. A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency. Blood 1994; 84:4234-41.
11. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76:275-85.
12. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989; 7:445-80.
13. Bierer BE, Burakoff SJ. T cell receptors: adhesion and signaling. Adv Cancer Res 1991; 56:49-76.
14. Noelle RJ, Ledbetter JA, Aruffo A. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol Today 1992; 13:431-3.
15. Geha RS, Rosen FS. The genetic basis of immunoglobulin-class switching [editorial]. N Engl J Med 1994; 330:1008-9.
16. Dune FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15:406-11.
17. Noelle RJ. The role of gp39 (CD40L) in immunity. Clin Immunol Immunopathol 1995; 76:5203-7.
18. Gordon J. CD40 and its ligand: central players in B lymphocyte survival, growth, and differentiation. Blood Rev 1995; 9:53-56.
19. Fuleihan R, Ramesh N, Loh R et al. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 1993; 90:2170-3.
20. Korthäuer U, Graf D, Mages HW et al. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 1993; 361:539-41.
21. Aruffo A, Farrington M, Hollenbaugh D et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 1993; 72:291-300.
22. Farrington M, Grosmaire LS, Nonoyama S et al. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 1994; 91:1099-103.
23. Ruegg CL, Rajasekar S, Stein BS, Engleman EG. Degradation of CD4 following phorbol-induced internalization in human T lymphocytes. Evidence for distinct endocytic routing of CD4 and CD3. J Biol Chem 1992; 267:18837-43.
24. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DANN and proteins from cell and tissue samples. BioTechniques 1993; 15:532-4.
25. Hollenbaugh D, Grosmaire LS, Kullas CD et al. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J 1992; 11:4313-21.
26. Foley KP, Leonard MW, Engel JD. Quantitaten of RNA using the polymerase chain reaction. Trends Genet 1993; 9:380-5.
27. + peripheral blood lymphocytes. J Immunol 1992; 149:3278-89.
28. Fraser JD, Irving BA, Crabtree GR, Weiss A. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 1991; 251:313-6.
29. Fraser JD, Weiss A. Regulation of T-cell lymphokine gene transcription by the accessory molecule CD28. Mol Cell Biol 1992; 12:4357-63.
30. Jain J, Loh C, Rao A. Transcriptional regulation of the IL-2 gene. Curr Opin Immunol 1995; 7:333-42.
31. Klaus SJ, Pinchuk LM, Ochs HD, Law CL, Fanslow WC, Armitage RJ, Clark EA. Costimulation through CD28 enhances T cell-dependent B cell activation via CD40-CD40L interaction. J Immunol 1994; 152:5643-52.
32. Keightley RG, Cooper MD, Lawton AR. The T cell dependence of B cell differentiation induced by pokeweed mitogen. J Immunol 1976; 117:1538-44.
33. + T cell subset expressing homing-receptor L-selectin. J Immunol 1994; 152:4417-24.
34. Fischer MB, Wolf HM, Eggenbauer H et al. The costimulatory signal CD28 is fully functional but cannot correct the impaired antigen response in T cells of patients with common variable immunodeficiency. Clin Exp Immunol 1994; 95:209-14.
35. + T cells. Clin Exp Immunol 1995; 101:82-88.
36. Waldmann TA, Durm M, Broder S, Blackman M, Blaese RM, Strober W. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. Lancet 1974; 2:609-13.
37. Broom BC, De la Concha EG, Webster AD, Janossy GJ, Asherson GL. Intracellular immunoglobulin production in vitro by lymphocytes from patients with hypogammaglobulinaemia and their effect on normal lymphocytes. Clin Exp Immunol 1976; 23:73-77.
38. De la Concha EG, Oldham G, Webster AD, Asherson GL, Platts-Mills TA. Quantitative measurements of T- and B-cell function in 'variable' primary hypogammaglobulinaemia: evidence for a consistent B-cell defect. Clin Exp Immunol 1977; 27:208-15.
39. + T cells define a unique subset of patients with common variable immunodeficiency. Blood 1993; 82:192-200.
40. Jaffe JS, Eisenstein E, Sneller MC, Strober W. T-cell abnormalities in common variable immunodeficiency. Pediatr Res 1993; 33:S24-27.
41. North ME, Akbar AN, Borthwick N, Sagawa K, Funauchi M, Webster AD, Farrant J. Co-stimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency. Clin Exp Immunol 1994; 95:204-8.
42. Pastor MI, Reif K, Cantrell D. The regulation and function of p21 ras during T-cell activation and growth. Immunol Today 1995; 16:159-64.
43. D'Ambrosio D, Cantrell DA, Frati L, Santoni A, Testi R. Involvement of p21ras activation in T cell CD69 expression. Eur J Immunol 1994; 24:616-20.
44. Testi R, D'Ambrosio D, De Maria R, Santoni A. The CD69 receptor a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today 1994; 15:479-83.
45. Fuleihan R, Ramesh N, Horner A et al. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest 1994; 93:1315-20.
46. Fuleihan R, Ahem D, Geha RS. Expression of the CD40 ligand in T lymphocytes and induction of IgE isotype switching. Int Arch Allergy Immunol 1995; 107:43-44.
47. Fischer MB, Wolf HM, Hauber I, Eggenbauer H, Thon V, Sasgary M. Eibl MM. Activation via the antigen receptor is impaired in T cells, but not in B cells from patients with common variable immunodeficiency. Eur J Immunol 1996; 26:231-7.
48. Spickett GP, Farrant J, North ME, Zhang J-G, Morgan L, Webster ADB. Common variable immunodeficiency: how many diseases? Immunol Today 1997; 18:325-8.